Research on GLP-1 focuses mainly on its role in stimulating insulin secretion by activating pancreatic beta cells and the potential use of hormone analogs for the treatment of type 2 diabetes and obesity. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.